lobbying_activities: 1885584

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1885584	5b737898-6d5d-4be6-baf5-1092ec5a0cc9	Q3	FORBES-TATE	400976792	PHRMA	2016	third_quarter	PHA	Issues related to Medicare Part D; issues related to the drug industry, issues related to comparative effectiveness; issues related to follow-on biologics; issues related to the Independent Payment Advisory Board; issues related to patent reform; issues related to ASP+6 and Part B rule; issues related to PCORI; issues related to pharmaceutical drug safety track and trace program legislation; issues related to low income subsidies; issues related to the Vice President's National Cancer Moonshot Initiative.	HOUSE OF REPRESENTATIVES,SENATE	80000		0	0	2016-10-19T10:57:33.233000-04:00